This website uses cookies to enhance the user experience.
||
M

MEDI PARTNER HOLDING AS989 197 606

Purchase and sale
Limited company
Tomteveien 33 1618 FREDRIKSTAD, Norge

MEDI PARTNER HOLDING AS

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

Chairman of the board
Years since formation
19 years
since Feb 6, 2006
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
100
1 share class
Total number of shareholders
3
persons
Belongs to group of

Financials

Annual total result 2024
-11,943,617
NOK
Total equity 2024
132,759,014
NOK
Last update: Aug 11, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
52 %
directly

Board

NameRoleShares
Chairman
52 %
directly
Board Member-
Board Member
24 %
directly
Board Member
24 %
directly

Others

NameRoleShares
B
BDO AS
Auditor-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
52 %
directly
Board Member
24 %
directly
Board Member
24 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
52
52 %
Ordinary shares
24
24 %
Ordinary shares
24
24 %

Shares owned by the MEDI PARTNER HOLDING AS

NameShare classTotal number of sharesShare
I
INDUSTRIVEIEN 3 EIENDOM AS
Ordinary shares
300,000
100 %
L
LEA INVEST AS
Ordinary shares
100
100 %
M
MEDI PARTNER AS
Ordinary shares
2,400,000
100 %
P
PALETT AS
Ordinary shares
546
36.4 %
M
MEDTHINGS AS
Ordinary shares
27,330
2.88 %
F
Ordinary shares
25
0.66 %
Z
ZOBRIUS PHARMA ASA
Ordinary shares
60,000
0.33 %
I
INSULIFE AS
NO0012753625
200,000
0.28 %
A
ATHLERA AS
Ordinary shares
15,200
0.04 %
Last update: Jun 2, 2025

Group structure

Financials

in NOK

Summary

Year2024202320222021
Total operating income
0
0
0
0
Annual Total Result
-11,943,617
49,599,408
82,191,686
44,163,347
Total assets
147,715,177
168,985,821
233,185,292
79,467,468
Total liabilities
14,956,163
14,283,190
107,482,070
35,955,931
Total equity
132,759,014
154,702,631
125,703,223
43,511,536

P&L

Year2024202320222021
Total operating income
0
0
0
0
Total operating costs
3,284,925
216,487
261,124
252,402
Operating result
-3,284,925
-216,487
-261,124
-252,402
Financial income/costs
-8,190,261
50,591,685
82,762,108
44,370,160
Profit before tax
-11,475,187
50,375,198
82,500,984
44,117,758
Total tax & extraordinary income/cost
468,430
775,790
309,298
-45,589
Annual Total Result
-11,943,617
49,599,408
82,191,686
44,163,347

Balance overview

Year2024202320222021
Total fixed assets
8,435,573
14,812,995
6,240,824
3,229,021
Total current assets
139,279,604
154,172,826
226,944,468
76,238,447
Total assets
147,715,177
168,985,821
233,185,292
79,467,468
Short term debt
14,956,163
14,283,190
107,482,070
35,955,931
Long term debt
0
0
0
0
Total liabilities
14,956,163
14,283,190
107,482,070
35,955,931
Contributed capital
74,951
74,951
74,951
74,951
Retained earnings
132,684,063
154,627,680
125,628,272
43,436,585
Total equity
132,759,014
154,702,631
125,703,223
43,511,536
Total equity and liabilities
147,715,177
168,985,821
233,185,292
79,467,468

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods